Q: What is Omnitrope used for?

Omnitrope is used to treat growth hormone deficiency .

Q: How does Omnitrope work?

Mechanism of Action Omnitrope contains somatropin, which is a recombinant human growth hormone. It is designed to be identical to the growth hormone naturally produced by the pituitary gland. When injected, it travels through the bloodstream and binds to specific receptors on the surface of cells throughout the body to trigger growth processes. Growth Stimulation The primary function of this medication is to promote linear growth, especially in children whose bodies do not produce enough natural growth hormone. It works by: Stimulating the growth of long bones at the growth plates. Increasing the production of Insulin-like Growth Factor-1 (IGF-1), a hormone that helps carry out the effects of growth hormone. Increasing the number and size of skeletal muscle cells. Metabolic Effects Beyond physical height, Omnitrope plays a role in how the body processes nutrients and maintains tissues. It influences metabolism by: Promoting protein synthesis to build and repair tissues. Encouraging the body to use stored fat for energy. Helping the body retain essential minerals like phosphorus, magnesium, and potassium.

Q: What are the active ingredients in Omnitrope?

The active ingredient in Omnitrope is somatropin .

Q: What are the side effects of Omnitrope?

Common side effects of Omnitrope may include: injection site reactions joint pain muscle pain Always consult with a healthcare professional about potential side effects.

Q: What drug class is Omnitrope?

Omnitrope belongs to the recombinant human growth hormone drug class.

Q: What is the dosage of Omnitrope and how do I take it?

Administration Omnitrope is administered as a subcutaneous injection, meaning it is injected into the fatty tissue just under the skin. Common injection sites include the thighs, upper arms, abdomen, or buttocks. It is important to rotate the injection site with each dose to help prevent skin irritation or the loss of fat at the site. The medication is available in vials for use with a syringe or in cartridges for use with a specific delivery pen. When preparing the injection, the solution should not be shaken, as vigorous shaking can damage the medication. Before use, check the liquid to ensure it is clear and colorless. If the solution is cloudy, discolored, or contains visible particles, it should not be used. Dosing Schedule Injections are typically given once per day, often in the evening. A healthcare provider will determine the appropriate schedule based on the condition being treated and the patient's response to the medication. Missed Dose If a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular schedule should be resumed. Do not take two doses at once to make up for a missed one. If more than three doses in a row are missed, contact a healthcare provider for further instructions.

Q: Is Omnitrope safe during pregnancy and breastfeeding?

Pregnancy It is not known whether Omnitrope can cause harm to an unborn baby or affect the ability to become pregnant. Animal reproduction studies have not been performed with this medication, and human data are limited. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your doctor. Omnitrope is generally only used during pregnancy if it is clearly needed. Breastfeeding There is no information available on whether Omnitrope passes into breast milk or how it might affect a nursing child. Because the risks are unknown, it is important to consult with a healthcare professional to weigh the benefits of treatment against any potential risks to the infant before breastfeeding while using this medication.

Q: What is the FDA approval status of Omnitrope?

FDA Approval History Omnitrope (somatropin) was approved by the U.S. Food and Drug Administration (FDA) in May 2006. It was the first follow-on version of a recombinant human growth hormone to be approved under the 505(b)(2) regulatory pathway, which allows the FDA to rely on existing safety and efficacy data from a previously approved reference product. Approved Indications The FDA has approved Omnitrope for several specific conditions involving growth hormone deficiency or growth failure: Pediatric Patients: Treatment of growth failure due to growth hormone deficiency (GHD), Prader-Willi syndrome, being born small for gestational age (SGA), Turner syndrome, and idiopathic short stature. Adult Patients: Replacement of endogenous growth hormone in adults with growth hormone deficiency that began in either childhood or adulthood. Regulatory Status and Safety Omnitrope is a prescription medication and is not a controlled substance, though its distribution and use are strictly regulated. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required for this medication. However, it is contraindicated in patients with active malignancy, acute critical illness, or certain types of severe respiratory impairment. The FDA requires that the medication be used only for its approved indications under the supervision of a healthcare provider.

Question 1

What is Omnitrope?

Accepted Answer

Omnitrope is a recombinant human growth hormone, also known as somatropin. It is produced using biotechnology to be identical to the growth hormone naturally secreted by the human pituitary gland.

This medication acts as a replacement for natural growth hormone to support essential physiological processes. It is designed to help regulate metabolism and maintain hormonal balance in the body.

Question 2

What is Omnitrope used for?

Accepted Answer

Omnitrope is used to treat growth hormone deficiency.

Question 3

How does Omnitrope work?

Accepted Answer

Mechanism of Action

Omnitrope contains somatropin, which is a recombinant human growth hormone. It is designed to be identical to the growth hormone naturally produced by the pituitary gland. When injected, it travels through the bloodstream and binds to specific receptors on the surface of cells throughout the body to trigger growth processes.

Growth Stimulation

The primary function of this medication is to promote linear growth, especially in children whose bodies do not produce enough natural growth hormone. It works by:

Stimulating the growth of long bones at the growth plates.
Increasing the production of Insulin-like Growth Factor-1 (IGF-1), a hormone that helps carry out the effects of growth hormone.
Increasing the number and size of skeletal muscle cells.

Metabolic Effects

Beyond physical height, Omnitrope plays a role in how the body processes nutrients and maintains tissues. It influences metabolism by:

Promoting protein synthesis to build and repair tissues.
Encouraging the body to use stored fat for energy.
Helping the body retain essential minerals like phosphorus, magnesium, and potassium.

Question 4

What are the active ingredients in Omnitrope?

Accepted Answer

The active ingredient in Omnitrope is somatropin.

Question 5

What are the side effects of Omnitrope?

Accepted Answer

Common side effects of Omnitrope may include:

injection site reactions
joint pain
muscle pain

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Omnitrope?

Accepted Answer

Omnitrope belongs to the recombinant human growth hormone drug class.

Question 7

What is the dosage of Omnitrope and how do I take it?

Accepted Answer

Administration

Omnitrope is administered as a subcutaneous injection, meaning it is injected into the fatty tissue just under the skin. Common injection sites include the thighs, upper arms, abdomen, or buttocks. It is important to rotate the injection site with each dose to help prevent skin irritation or the loss of fat at the site.

The medication is available in vials for use with a syringe or in cartridges for use with a specific delivery pen. When preparing the injection, the solution should not be shaken, as vigorous shaking can damage the medication. Before use, check the liquid to ensure it is clear and colorless. If the solution is cloudy, discolored, or contains visible particles, it should not be used.

Dosing Schedule

Injections are typically given once per day, often in the evening. A healthcare provider will determine the appropriate schedule based on the condition being treated and the patient's response to the medication.

Missed Dose

If a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular schedule should be resumed. Do not take two doses at once to make up for a missed one. If more than three doses in a row are missed, contact a healthcare provider for further instructions.

Question 8

Is Omnitrope safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is not known whether Omnitrope can cause harm to an unborn baby or affect the ability to become pregnant. Animal reproduction studies have not been performed with this medication, and human data are limited. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits with your doctor. Omnitrope is generally only used during pregnancy if it is clearly needed.

Breastfeeding

There is no information available on whether Omnitrope passes into breast milk or how it might affect a nursing child. Because the risks are unknown, it is important to consult with a healthcare professional to weigh the benefits of treatment against any potential risks to the infant before breastfeeding while using this medication.

Question 9

What forms and strengths does Omnitrope come in?

Accepted Answer

Omnitrope is provided as a subcutaneous injection in two primary formats:

Cartridges: These contain a clear, colorless solution intended for use with a compatible pen injector device.
Vials: This format consists of a lyophilized powder that must be mixed with a liquid diluent before administration.

Question 10

What is the FDA approval status of Omnitrope?

Accepted Answer

FDA Approval History

Omnitrope (somatropin) was approved by the U.S. Food and Drug Administration (FDA) in May 2006. It was the first follow-on version of a recombinant human growth hormone to be approved under the 505(b)(2) regulatory pathway, which allows the FDA to rely on existing safety and efficacy data from a previously approved reference product.

Approved Indications

The FDA has approved Omnitrope for several specific conditions involving growth hormone deficiency or growth failure:

Pediatric Patients: Treatment of growth failure due to growth hormone deficiency (GHD), Prader-Willi syndrome, being born small for gestational age (SGA), Turner syndrome, and idiopathic short stature.
Adult Patients: Replacement of endogenous growth hormone in adults with growth hormone deficiency that began in either childhood or adulthood.

Regulatory Status and Safety

Omnitrope is a prescription medication and is not a controlled substance, though its distribution and use are strictly regulated. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required for this medication. However, it is contraindicated in patients with active malignancy, acute critical illness, or certain types of severe respiratory impairment. The FDA requires that the medication be used only for its approved indications under the supervision of a healthcare provider.

Question 11

What should I know about Omnitrope and cost?

Accepted Answer

Factors Influencing Cost

The price of Omnitrope treatment is not fixed and varies based on several individual factors:

Dosage and Weight: Because dosing is often based on body weight or specific medical needs, patients requiring higher doses will face higher total costs.
Insurance Coverage: Most insurance providers require prior authorization before they will cover growth hormone therapy. The final out-of-pocket cost depends on the specific plan's deductible, copay, or coinsurance requirements.
Pharmacy Type: Omnitrope is usually dispensed through specialty pharmacies rather than standard retail pharmacies, which can affect pricing and delivery fees.

Financial Assistance and Savings

There are options available that may help reduce the cost of Omnitrope for eligible patients:

Co-pay Cards: The manufacturer may offer savings cards for patients with commercial insurance to help lower monthly out-of-pocket expenses.
Patient Assistance Programs: For individuals without insurance or those who meet specific low-income criteria, programs may be available to provide the medication at a reduced cost or for free.
Biosimilar Status: Omnitrope was the first biosimilar follow-on biologic approved in the United States, which can sometimes make it a more cost-effective option compared to other brand-name growth hormones.

Omnitrope

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Omnitrope

Hospitals.net Disclosure